ULBI icon

Ultralife

8.62 USD
-0.19
2.16%
At close Jul 11, 4:00 PM EDT
1 day
-2.16%
5 days
-3.15%
1 month
15.70%
3 months
82.63%
6 months
14.17%
Year to date
16.64%
1 year
-21.06%
5 years
35.32%
10 years
114.96%
 

About: Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Employees: 671

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

4% more funds holding

Funds holding: 67 [Q4 2024] → 70 (+3) [Q1 2025]

2.08% less ownership

Funds ownership: 37.73% [Q4 2024] → 35.64% (-2.08%) [Q1 2025]

32% less capital invested

Capital invested by funds: $46.7M [Q4 2024] → $31.9M (-$14.9M) [Q1 2025]

43% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 30

89% less call options, than puts

Call options by funds: $1K | Put options by funds: $9K

Research analyst outlook

We haven’t received any recent analyst ratings for ULBI.

Financial journalist opinion

Positive
Seeking Alpha
1 week ago
Ultralife Loses Place On Index, But Is Rebounding Robustly
Ultralife was removed from the FTSE Russell 3000 Microcap Index due to a share price slump, but fundamentals remain strong, and recovery is underway. Recent earnings show robust revenue and EPS growth, boosted by the Electrochem acquisition and improved productivity, supporting a bullish outlook. The valuation remains attractive, with forecasted EPS growth and a one-year price target of $14.12, representing a significant upside from current levels.
Ultralife Loses Place On Index, But Is Rebounding Robustly
Positive
Seeking Alpha
1 week ago
Ultralife: Recharging Growth With Smart Acquisitions
Ultralife's revenue has been volatile in the past decade or so, but its recent comeback seems to have more legroom to grow. Through a series of recent acquisitions, the company has diversified its revenue dependence on government contracts and obtained access to a more domestic and overseas customer base. Key financial metrics demonstrate strong cash flow and organic integration of its acquisitions, supporting a positive outlook.
Ultralife: Recharging Growth With Smart Acquisitions
Neutral
Seeking Alpha
2 months ago
Ultralife Corporation (ULBI) Q1 2025 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ET Company Participants Alex Villalta - Investor Relations Mike Manna - President & Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company Justin Mechetti - Sidoti & Company Operator Good day and thank you for standing by. Welcome to the Ultralife Corporation First Quarter 2025 Results.
Ultralife Corporation (ULBI) Q1 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
2 months ago
Ultralife Corporation Reports First Quarter Results
NEWARK, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2025 with the following highlights:
Ultralife Corporation Reports First Quarter Results
Neutral
Seeking Alpha
3 months ago
Ultralife Corporation (ULBI) Q4 2024 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q4 2024 Earnings Conference Call April 1, 2025 8:30 AM ET Company Participants Alex Villalta - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Fourth Quarter 2024 Results.
Ultralife Corporation (ULBI) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
3 months ago
Ultralife Corporation Reports Fourth Quarter Results
Acquisition of Electrochem Completed and Integration Has Commenced                 NEWARK, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows: Fourth Quarter: Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7% increase in Battery & Energy Products sales and a 55.1% decrease in Communications Systems sales Gross profit of $10.6 million, or 24.2% of revenue, compared to $11.4 million, or 25.6% of revenue, for the 2023 fourth quarter Operating income of $1.5 million, including one-time costs and GAAP adjustments of $1.1 million directly related to the acquisition of Electrochem Solutions, Inc. (“Electrochem”) on October 31, 2024, compared to $3.6 million for the 2023 fourth quarter GAAP EPS of $0.01 compared to $0.17 for the 2023 fourth quarter Adjusted EBITDA of $3.9 compared to $4.8 million for the 2023 fourth quarter Backlog and high confidence orders of $102.2 million exiting 2024 compared to $78.0 exiting the third quarter Fiscal Year 2024: Sales of $164.5 million represent a 3.7% year-over-year increase; essentially flat with 2023 when excluding Electrochem Operating income of $10.0 million including one-time costs and GAAP adjustments of $1.4 million directly related to the acquisition of Electrochem on October 31, 2024, versus $9.5 million for 2023 GAAP EPS of $0.38 compared to $0.44 for 2023 which included approximately $0.08 for recognition of the ERC filed under the Coronavirus Aid, Relief and Economic Act Adjusted EBITDA of $16.5 million compared to $15.7 million for 2023 “For the fourth quarter the contribution of Electrochem compensated for delays in the timing of expected larger orders for our Communications Systems segment and customer requests to push orders into 2025 for our Battery & Energy Products segment.
Ultralife Corporation Reports Fourth Quarter Results
Neutral
GlobeNewsWire
3 months ago
Ultralife Corporation to Report Fourth Quarter Results on April 1, 2025
NEWARK, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2024 before the market opens on Tuesday, April 1, 2025.
Ultralife Corporation to Report Fourth Quarter Results on April 1, 2025
Neutral
GlobeNewsWire
4 months ago
Ultralife Corporation Files Form 12b-25 Notification of Late Filing
NEWARK, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI), today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
Ultralife Corporation Files Form 12b-25 Notification of Late Filing
Neutral
GlobeNewsWire
4 months ago
Ultralife Corporation to Report Fourth Quarter Results on March 11, 2025
NEWARK, N.Y., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2024 before the market opens on Tuesday, March 11, 2025. Due to the time required to complete the accounting close and audit of the financial results of Electrochem Solutions, Inc., which the Company acquired on October 31, 2024, Ultralife is reporting fourth quarter results later than it has in the past, in contrast to its established practice of reporting fourth quarter results on the Thursday of the sixth week after year end.
Ultralife Corporation to Report Fourth Quarter Results on March 11, 2025
Neutral
GlobeNewsWire
6 months ago
Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans
Appoints Chief Marketing Officer and Senior Vice President – Sales & Business Development, Battery & Energy Products Appoints Chief Marketing Officer and Senior Vice President – Sales & Business Development, Battery & Energy Products
Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans
Charts implemented using Lightweight Charts™